Ara
Toplam kayıt 4, listelenen: 1-4
Association between previous anticoagulant use and mortality among hospitalized patients with COVID-19
(Springer, 02.06.2021)
Although COVID-19 disease primarily affects the respiratory system, it has been seen in many studies that it causes thromboembolic (TE) events in many tissues and organs. So that, to prevent TE can reduce mortality and ...
Adverse Cardiac Events Among the Patients Using Hydroxychloroquine and Azithromycin in COVID-19
(DOC TASARIM VE BİLİŞİM YAYINCILIK, 2020)
Background: Hydroxychloroquine (HQN) and azithromycin (AZ) were used in the treatment
of coronavirus disease 2019 (Covid-19), which might lead to cardiac side effects.
Aim: We aimed to describe the safety of HQN and ...
Relationship Between Blood Lipid Levels and Mortality in Hospitalized COVID-19 Patients
(SAGE Publications, 06.02.2022)
People with comorbid conditions are at increased risk of developing severe/fatal coronavirus disease 2019 (COVID-19). We aimed to investigate the relationship between lipid levels and mortality in patients hospitalized for ...
Impact of drug interactions with direct oral anticoagulants on mortality in elderly with atrial fibrillation during the COVID-19 pandemic
(Elsevier, 15.07.2022)
Objective
To evaluate the effect of drug interactions with chronic direct oral anticoagulants (DOAC) on mortality in older atrial fibrillation (AF) patients during the Coronavirus disease 2019(COVID-19) pandemic.
Methods
We ...